Abel de la Rosa
Direttore/Membro del Consiglio presso VIRIOS THERAPEUTICS, INC.
Profilo
Abel de la Rosa is the founder of Antios Therapeutics, Inc. He is currently an Independent Director at Virios Therapeutics, Inc. since 2020.
Previously, he served as a Director at Celtaxsys, Inc. from 2012 to 2020.
Prior to that, he was the VP-Business Development & Scientific Affairs at Pharmasset, Inc. from 2002 to 2012.
Abel also held the position of Chief Scientific Officer at Drug Innovation Ventures At Emory LLC from 2012 to 2018, as well as at Emory Institute For Drug Development from 2012 to 2018.
Dr. de la Rosa obtained a doctorate degree from Miami University and an undergraduate degree from the University of California San Diego.
Posizioni attive di Abel de la Rosa
| Società | Posizione | Inizio |
|---|---|---|
| VIRIOS THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 21/12/2020 |
Antios Therapeutics, Inc.
 Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Fondatore | - |
Precedenti posizioni note di Abel de la Rosa
| Società | Posizione | Fine |
|---|---|---|
Celtaxsys, Inc.
 Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Direttore/Membro del Consiglio | 01/01/2020 |
| Drug Innovation Ventures At Emory LLC | Direttore Tecnico/Scientifico/R&S | 01/01/2018 |
Emory Institute For Drug Development
 Emory Institute For Drug Development Miscellaneous Commercial ServicesCommercial Services Emory Institute For Drug Development engages in drug discovery and development in industry and academia. It provides organization, facilities and resources to translate academic drug discovery into clinical candidates. The company was founded by Dennis C. Liotta in 2009 and is headquartered in Atlanta, GA. | Direttore Tecnico/Scientifico/R&S | 01/01/2018 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Direttore Tecnico/Scientifico/R&S | 01/01/2012 |
Formazione di Abel de la Rosa
| University of California San Diego | Undergraduate Degree |
| Miami University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VIRIOS THERAPEUTICS, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Antios Therapeutics, Inc.
Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Health Technology |
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Health Technology |
| Drug Innovation Ventures At Emory LLC | |
Emory Institute For Drug Development
Emory Institute For Drug Development Miscellaneous Commercial ServicesCommercial Services Emory Institute For Drug Development engages in drug discovery and development in industry and academia. It provides organization, facilities and resources to translate academic drug discovery into clinical candidates. The company was founded by Dennis C. Liotta in 2009 and is headquartered in Atlanta, GA. | Commercial Services |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
- Borsa valori
- Insiders
- Abel de la Rosa